Julie Ann Kish

机构：Moffitt Cancer Center

发表论文 115 篇 · 总被引 10713 次 · h-index 37

代表论文

• Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742) (2018 · Journal of Clinical Oncology · 被引 478)
• Adjuvant radiotherapy versus concurrent chemoradiotherapy for the management of high‐risk salivary gland carcinomas (2016 · Head & Neck · 被引 70)
• Radiotherapy with cetuximab or durvalumab for locoregionally advanced head and neck cancer in patients with a contraindication to cisplatin (NRG-HN004): an open-label, multicentre, parallel-group, randomised, phase 2/3 trial (2024 · The Lancet Oncology · 被引 64)
• The Older Adult With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: Knowledge Gaps and Future Direction in Assessment and Treatment (2017 · International Journal of Radiation Oncology*Biology*Physics · 被引 64)
• Concurrent Cetuximab and Nivolumab as a Second-Line or beyond Treatment of Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results of Phase I/II Study (2021 · Cancers · 被引 60)
• Adherence and persistence of mirabegron and anticholinergic therapies in patients with overactive bladder: a real-world claims data analysis (2017 · International Journal of Clinical Practice · 被引 58)